Your browser doesn't support javascript.
loading
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
Diro, Ermias; Blesson, Severine; Edwards, Tansy; Ritmeijer, Koert; Fikre, Helina; Admassu, Henok; Kibret, Aderajew; Ellis, Sally J; Bardonneau, Clelia; Zijlstra, Eduard E; Soipei, Peninah; Mutinda, Brian; Omollo, Raymond; Kimutai, Robert; Omwalo, Gabriel; Wasunna, Monique; Tadesse, Fentahun; Alves, Fabiana; Strub-Wourgaft, Nathalie; Hailu, Asrat; Alexander, Neal; Alvar, Jorge.
Afiliación
  • Diro E; Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
  • Blesson S; Research & Development Department, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Edwards T; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Ritmeijer K; Médecins sans Frontières, Amsterdam, the Netherlands.
  • Fikre H; Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
  • Admassu H; Abdurafi Health Centre, Médecins sans Frontières, Abdurafi, Ethiopia.
  • Kibret A; Abdurafi Health Centre, Médecins sans Frontières, Abdurafi, Ethiopia.
  • Ellis SJ; Research & Development Department, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Bardonneau C; Research & Development Department, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Zijlstra EE; Research & Development Department, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Soipei P; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Mutinda B; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Omollo R; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Kimutai R; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Omwalo G; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Wasunna M; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Tadesse F; Neglected Tropical Diseases, Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Alves F; Research & Development Department, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Strub-Wourgaft N; Research & Development Department, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Hailu A; Department of Microbiology, Immunology, and Parasitology, Addis Ababa University, Addis Ababa, Ethiopia.
  • Alexander N; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Alvar J; Research & Development Department, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
PLoS Negl Trop Dis ; 13(1): e0006988, 2019 01.
Article en En | MEDLINE | ID: mdl-30653490
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosforilcolina / Anfotericina B / Leishmaniasis Visceral / Antiprotozoarios Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: PLoS Negl Trop Dis Asunto de la revista: MEDICINA TROPICAL Año: 2019 Tipo del documento: Article País de afiliación: Etiopia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosforilcolina / Anfotericina B / Leishmaniasis Visceral / Antiprotozoarios Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: PLoS Negl Trop Dis Asunto de la revista: MEDICINA TROPICAL Año: 2019 Tipo del documento: Article País de afiliación: Etiopia Pais de publicación: Estados Unidos